Template:CMV retinitis treatment: Difference between revisions

(Marked this version for translation)
(Strip translate tags to enable SMW subobject creation)
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
<noinclude><languages/></noinclude>
====Severe Vision Threatening==== *Ganciclovir intraocular implant for 8 months AND
<translate>
**{{AntibioticDose|disease=CMV retinitis|drug=Valganciclovir|dose=900mg PO q12hrs x 14 days then 900mg PO q24hrs x 7 days|context=Severe vision threatening with intraocular implant|population=Adult}}


====Severe Vision Threatening==== <!--T:1-->


<!--T:2-->
====Peripheral lesions==== *{{AntibioticDose|disease=CMV retinitis|drug=Valganciclovir|dose=900mg PO q12hrs x 21 days then 900mg PO q24hrs x 7 days|context=Peripheral lesions|population=Adult}}
*Ganciclovir intraocular implant for 8 months AND
**Valganciclovir 900mg PO q12hrs x 14 days FOLLOWED BY 900mg PO q24hrs x 7 days
 
 
====Peripheral lesions==== <!--T:3-->
 
<!--T:4-->
*Valganciclovir 900mg PO q12hrs x 21 days FOLLOWED BY 900mg PO q24hrs x 7 days
</translate>

Latest revision as of 02:54, 20 March 2026

====Severe Vision Threatening==== *Ganciclovir intraocular implant for 8 months AND

    • Valganciclovir 900mg PO q12hrs x 14 days then 900mg PO q24hrs x 7 days


====Peripheral lesions==== *Valganciclovir 900mg PO q12hrs x 21 days then 900mg PO q24hrs x 7 days

Retrieved from "https://www.wikem.org/w/index.php?title=Template:CMV_retinitis_treatment&oldid=386614"